Skip to main content
Thorax logoLink to Thorax
. 1975 Feb;30(1):2–8. doi: 10.1136/thx.30.1.2

An analysis of skin prick test reactions in 656 asthmatic patients.

D J Hendrick, R J Davies, M F D'Souza, J Pepys
PMCID: PMC470237  PMID: 1168378

Abstract

Of 656 asthmatic patients referred specifically for allergy assessments, 544 (84 percent) gave positive immediate skin prick tests to at least one of 22 common allergens used routinely. Comparison of these skin test positive patients with the 102 (16 percent) who were skin test negative showed a number of significant differences. The majority of the skin test positive patients (52 percent) were less than 10 years old at the time of onset of the asthma, whereas, of the skin test negative patients, 56 percent were aged over 30 years at the time of onset. Seventy per cent report rhinitis compared with 48 per cent of the skin test negative patients, and 29 per cent reported infantile eczema compared with 9 per cent. Symptoms attributed to house dust, pollens, and animals were noted two to three times more frequently by the skin test positive patients, while corticosteroid drugs had been used more commonly by the skin test negative patients (45 percent compared with 35 percent). No significant differences were observed with the other factors studied, namely, history of urticaria or angio-oedema, family history of "allergic" disease, and awareness of sensitivity to foods, aspirin or penicillin. Prick test reactions in the skin test positive patients were most commonly seen to house dust or the acarine mite, Dermatophagoides farinae (82 percent), followed by pollens (66 percent), animal danders (38 percent), foods (16 percent), Aspergillus fumigatus (16 percent), and other moulds (21 percent). There was a highly significant association of positive history with positive prick test for all allergens studied.

Full text

PDF
2

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aas K., Johansson S. G. The radioallergosorbent test in the in vitro diagnosis of multiple reaginic allergy. A comparison of diagnostic approaches. J Allergy Clin Immunol. 1971 Sep;48(3):134–142. doi: 10.1016/0091-6749(71)90008-x. [DOI] [PubMed] [Google Scholar]
  2. Balcon R., Maloy W. C., Sowton E. Clinical use of atrial pacing test in angina pectoris. Br Med J. 1968 Jul 13;3(5610):91–92. doi: 10.1136/bmj.3.5610.91. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barrett A. M., Carter J. Comparative chronotropic activity of beta-adrenoceptive antagonists. Br J Pharmacol. 1970 Nov;40(3):373–381. doi: 10.1111/j.1476-5381.1970.tb10619.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coltart D. J. Comparison of effects of propranolol and practolol on exercise tolerance in angina pectoris. Br Heart J. 1971 Jan;33(1):62–64. doi: 10.1136/hrt.33.1.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fitzgerald J. D. A new test of the degree of adrenergic beta receptor blockade. Int Z Klin Pharmakol Ther Toxikol. 1970 Dec;4(1):125–130. [PubMed] [Google Scholar]
  6. Ford R. M. Aetiology of asthma: a review of 11,551 cases (1958 to 1968). Med J Aust. 1969 Mar 22;1(12):628–631. doi: 10.5694/j.1326-5377.1969.tb92346.x. [DOI] [PubMed] [Google Scholar]
  7. Gibson D. G. Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man. Drugs. 1974;7(1):8–38. doi: 10.2165/00003495-197407010-00002. [DOI] [PubMed] [Google Scholar]
  8. Gillam P. M., Prichard B. N. Propranolol in the therapy of angina pectoris. Am J Cardiol. 1966 Sep;18(3):366–369. doi: 10.1016/0002-9149(66)90055-5. [DOI] [PubMed] [Google Scholar]
  9. Grandjean T., Rivier J. L. Cardio-circulatory effects of beta-adrenergic blockade in organic heart disease. Comparison between propranolol and CIBA 39,089-Ba. Br Heart J. 1968 Jan;30(1):50–59. doi: 10.1136/hrt.30.1.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Heterington D. J., Comerford M. B., Nyberg G., Besterman E. M. Comparison of two adrenergic beta-receptor blocking agents, alprenolol and propranolol, in treatment of angina pectoris. Br Heart J. 1973 Mar;35(3):320–333. doi: 10.1136/hrt.35.3.320. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hill R. C., Turner P. Preliminary investigations of a new beta-adrenoceptive receptor blocking drug, LB46, in man. Br J Pharmacol. 1969 Jun;36(2):368–372. doi: 10.1111/j.1476-5381.1969.tb09511.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Johansson S. G. Raised levels of a new immunoglobulin class (IgND) in asthma. Lancet. 1967 Nov 4;2(7523):951–953. doi: 10.1016/s0140-6736(67)90792-1. [DOI] [PubMed] [Google Scholar]
  13. Kerber R. E., Goldman R. H., Alderman E. L., Harrison D. C. Circulatory responses to beta adrenergic blockade with alprenolol. Studies in patients with chronic heart disease. Am J Cardiol. 1972 Jan;29(1):26–32. doi: 10.1016/0002-9149(72)90411-0. [DOI] [PubMed] [Google Scholar]
  14. McAllen M. K., Assem E. S., Maunsell K. House-dust mite asthma. Results of challenge tests on five criteria with Dermatophagoides pteronyssinus. Br Med J. 1970 May 30;2(5708):501–504. doi: 10.1136/bmj.2.5708.501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. PEARSON R. S. B. Natural history of asthma. Acta Allergol. 1958;12(4-5):277–294. doi: 10.1111/j.1398-9995.1958.tb03084.x. [DOI] [PubMed] [Google Scholar]
  16. Pepys J., Chan M., Hargreave F. E. Mites and house-dust allergy. Lancet. 1968 Jun 15;1(7555):1270–1272. doi: 10.1016/s0140-6736(68)92290-3. [DOI] [PubMed] [Google Scholar]
  17. RACKEMANN F. M., EDWARDS M. C. A follow-up study of 688 patients after an interval of twenty years. N Engl J Med. 1952 May 22;246(21):815–contd. doi: 10.1056/NEJM195205222462104. [DOI] [PubMed] [Google Scholar]
  18. Sealey B. J., Liljedal J., Nyberg G., Ablad B. Acute effects of oral alprenolol on exercise tolerance in patients with angina pectoris. A dose-response study. Br Heart J. 1971 Jul;33(4):481–488. doi: 10.1136/hrt.33.4.481. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Smith J. M. Skin tests and atopic allergy in children. Clin Allergy. 1973 Sep;3(3):269–275. doi: 10.1111/j.1365-2222.1973.tb01333.x. [DOI] [PubMed] [Google Scholar]
  20. Sowton E., Smithen C. Double-blind three-dose trial of oral alprenolol in angina pectoris. Br Heart J. 1971 Jul;33(4):601–606. doi: 10.1136/hrt.33.4.601. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Stenius B., Wide L., Seymour W. M. Clinical significance of total IgE and of specific IgE to Dermatophagoides spp., grass pollen and other common allergens. II. Relationship to clinical manifestations. Clin Allergy. 1972 Dec;2(4):303–306. doi: 10.1111/j.1365-2222.1972.tb01294.x. [DOI] [PubMed] [Google Scholar]
  22. Thadani U., Sharma B., Meeran M. K., Majid P. A., Whitaker W., Taylor S. H. Comparison of adrenergic beta-receptor antagonists in angina pectoris. Br Med J. 1973 Jan 20;1(5846):138–142. doi: 10.1136/bmj.1.5846.138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. WILLIAMS D. A., LEWIS-FANING E., REES L., JACOBS J., THOMAS A. Assessment of the relative importance of the allergic, infective and psychological factors in asthma. Acta Allergol. 1958;12(6):376–395. doi: 10.1111/j.1398-9995.1958.tb04007.x. [DOI] [PubMed] [Google Scholar]
  24. Wilson D. F., Watson O. F., Peel J. S., Langley R. B., Turner A. S. Some haemodynamic effects of trasicor (Ciba 39,089-Ba). N Z Med J. 1968 Sep;68(436):145–149. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES